F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment

Durata: 9 min
Dopo 30 giorni EUR 9,99/mese

Sintesi dell'editore

A Food and Drug Administration panel opened a new era in medicine on Wednesday, unanimously recommending that the agency approve the first treatment that genetically alters a patient’s own cells to fight cancer, transforming them into what scientists call “a living drug” that powerfully bolsters the immune system to shut down the disease.

"F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment" is from the July 12, 2017 U.S. section of The New York Times. It was written by Denise Grady and narrated by Keith Sellon-Wright.

©2017 The New York Times News Service Division of The New York Times Company (P)2017 Audible, Inc.
Cosa ne pensano gli iscritti
Valutazione media degli utenti

Non ci sono recensioni disponibili